Annual CFI
$1.35 M
+$1.54 M+797.41%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual cash flow from investing activities is $1.35 million, with the most recent change of +$1.54 million (+797.41%) on December 31, 2023.
- During the last 3 years, TCRT annual CFI has risen by +$11.12 million (+113.77%).
- TCRT annual CFI is now at all-time high.
Performance
TCRT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, TCRT quarterly CFI has stayed the same.
- TCRT quarterly CFI is now -100.00% below its all-time high of $2.98 million, reached on September 30, 2006.
Performance
TCRT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$1.50 M
-$1000.00-0.07%
September 30, 2024
Summary
- As of February 7, 2025, TCRT TTM cash flow from investing activities is $1.50 million, with the most recent change of -$1000.00 (-0.07%) on September 30, 2024.
- Over the past year, TCRT TTM CFI has dropped by -$1000.00 (-0.07%).
- TCRT TTM CFI is now -62.39% below its all-time high of $4.00 million, reached on March 31, 2007.
Performance
TCRT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TCRT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +797.4% | 0.0% | -0.1% |
| 3 y3 years | +113.8% | +100.0% | +122.3% |
| 5 y5 years | +393.3% | +100.0% | +124.6% |
TCRT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.5% | -100.0% | +100.0% | -0.1% | +145.2% |
| 5 y | 5-year | at high | +113.8% | -100.0% | +100.0% | -0.1% | +115.1% |
| alltime | all time | at high | +113.8% | -100.0% | +100.0% | -62.4% | +115.1% |
Alaunos Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $1.50 M(-0.1%) |
| Jun 2024 | - | $0.00(0.0%) | $1.50 M(+9.9%) |
| Mar 2024 | - | $0.00(-100.0%) | $1.37 M(+1.7%) |
| Dec 2023 | $1.35 M(-797.4%) | $1.50 M(>+9900.0%) | $1.35 M(-638.4%) |
| Sep 2023 | - | $1000.00(-100.7%) | -$250.00 K(-5.7%) |
| Jun 2023 | - | -$135.00 K(+487.0%) | -$265.00 K(+41.7%) |
| Mar 2023 | - | -$23.00 K(-75.3%) | -$187.00 K(-3.1%) |
| Dec 2022 | -$193.00 K(-94.2%) | -$93.00 K(+564.3%) | -$193.00 K(-58.0%) |
| Sep 2022 | - | -$14.00 K(-75.4%) | -$459.00 K(-43.7%) |
| Jun 2022 | - | -$57.00 K(+96.6%) | -$815.00 K(-69.1%) |
| Mar 2022 | - | -$29.00 K(-91.9%) | -$2.63 M(-20.7%) |
| Dec 2021 | -$3.32 M(-66.0%) | -$359.00 K(-3.0%) | -$3.32 M(-50.6%) |
| Sep 2021 | - | -$370.00 K(-80.3%) | -$6.73 M(-19.6%) |
| Jun 2021 | - | -$1.88 M(+161.8%) | -$8.37 M(-16.1%) |
| Mar 2021 | - | -$717.00 K(-81.0%) | -$9.98 M(+2.1%) |
| Dec 2020 | -$9.78 M(+3343.0%) | -$3.77 M(+87.2%) | -$9.78 M(+60.0%) |
| Sep 2020 | - | -$2.01 M(-42.3%) | -$6.11 M(+45.3%) |
| Jun 2020 | - | -$3.49 M(+579.7%) | -$4.21 M(+434.6%) |
| Mar 2020 | - | -$513.00 K(+413.0%) | -$787.00 K(+177.1%) |
| Dec 2019 | -$284.00 K(-38.1%) | -$100.00 K(-6.5%) | -$284.00 K(+189.8%) |
| Sep 2019 | - | -$107.00 K(+59.7%) | -$98.00 K(-38.8%) |
| Jun 2019 | - | -$67.00 K(+570.0%) | -$160.00 K(-49.8%) |
| Mar 2019 | - | -$10.00 K(-111.6%) | -$319.00 K(-30.5%) |
| Dec 2018 | -$459.00 K(-37.7%) | $86.00 K(-150.9%) | -$459.00 K(-44.1%) |
| Sep 2018 | - | -$169.00 K(-25.2%) | -$821.00 K(+12.8%) |
| Jun 2018 | - | -$226.00 K(+50.7%) | -$728.00 K(+37.6%) |
| Mar 2018 | - | -$150.00 K(-45.7%) | -$529.00 K(-28.2%) |
| Dec 2017 | -$737.00 K(+33.8%) | -$276.00 K(+263.2%) | -$737.00 K(+35.7%) |
| Sep 2017 | - | -$76.00 K(+181.5%) | -$543.00 K(-20.0%) |
| Jun 2017 | - | -$27.00 K(-92.5%) | -$679.00 K(-9.7%) |
| Mar 2017 | - | -$358.00 K(+336.6%) | -$752.00 K(+36.5%) |
| Dec 2016 | -$551.00 K(+33.7%) | -$82.00 K(-61.3%) | -$551.00 K(-35.6%) |
| Sep 2016 | - | -$212.00 K(+112.0%) | -$856.00 K(+32.3%) |
| Jun 2016 | - | -$100.00 K(-36.3%) | -$647.00 K(+17.2%) |
| Mar 2016 | - | -$157.00 K(-59.4%) | -$552.00 K(+34.0%) |
| Dec 2015 | -$412.00 K(+113.5%) | -$387.00 K(>+9900.0%) | -$412.00 K(+1548.0%) |
| Sep 2015 | - | -$3000.00(-40.0%) | -$25.00 K(-78.4%) |
| Jun 2015 | - | -$5000.00(-70.6%) | -$116.00 K(-44.2%) |
| Mar 2015 | - | -$17.00 K(<-9900.0%) | -$208.00 K(+7.8%) |
| Dec 2014 | -$193.00 K(+47.3%) | $0.00(-100.0%) | -$193.00 K(-6.3%) |
| Sep 2014 | - | -$94.00 K(-3.1%) | -$206.00 K(+79.1%) |
| Jun 2014 | - | -$97.00 K(+4750.0%) | -$115.00 K(+505.3%) |
| Mar 2014 | - | -$2000.00(-84.6%) | -$19.00 K(-85.5%) |
| Dec 2013 | -$131.00 K(-91.6%) | -$13.00 K(+333.3%) | -$131.00 K(-32.8%) |
| Sep 2013 | - | -$3000.00(+200.0%) | -$195.00 K(-65.6%) |
| Jun 2013 | - | -$1000.00(-99.1%) | -$567.00 K(-62.7%) |
| Mar 2013 | - | -$114.00 K(+48.1%) | -$1.52 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | -$1.56 M(+34.9%) | -$77.00 K(-79.5%) | -$1.56 M(-14.9%) |
| Sep 2012 | - | -$375.00 K(-60.7%) | -$1.83 M(-2.1%) |
| Jun 2012 | - | -$953.00 K(+518.8%) | -$1.87 M(+72.8%) |
| Mar 2012 | - | -$154.00 K(-56.0%) | -$1.08 M(-6.3%) |
| Dec 2011 | -$1.16 M(+521.5%) | -$350.00 K(-15.5%) | -$1.16 M(+33.8%) |
| Sep 2011 | - | -$414.00 K(+150.9%) | -$864.00 K(+72.8%) |
| Jun 2011 | - | -$165.00 K(-27.3%) | -$500.00 K(+23.5%) |
| Mar 2011 | - | -$227.00 K(+291.4%) | -$405.00 K(+117.7%) |
| Dec 2010 | -$186.00 K(+1590.9%) | -$58.00 K(+16.0%) | -$186.00 K(+36.8%) |
| Sep 2010 | - | -$50.00 K(-28.6%) | -$136.00 K(+54.5%) |
| Jun 2010 | - | -$70.00 K(+775.0%) | -$88.00 K(+388.9%) |
| Mar 2010 | - | -$8000.00(0.0%) | -$18.00 K(+63.6%) |
| Dec 2009 | -$11.00 K(-91.6%) | -$8000.00(+300.0%) | -$11.00 K(-5.2%) |
| Sep 2009 | - | -$2000.00(<-9900.0%) | -$11.60 K(-17.1%) |
| Jun 2009 | - | $0.00(-100.0%) | -$14.00 K(-77.6%) |
| Mar 2009 | - | -$1000.00(-88.4%) | -$62.60 K(-52.2%) |
| Dec 2008 | -$131.00 K(-116.0%) | -$8600.00(+95.5%) | -$131.00 K(-46.0%) |
| Sep 2008 | - | -$4400.00(-90.9%) | -$242.60 K(-47.7%) |
| Jun 2008 | - | -$48.60 K(-30.0%) | -$464.00 K(-21.1%) |
| Mar 2008 | - | -$69.40 K(-42.3%) | -$588.20 K(-172.0%) |
| Dec 2007 | $817.00 K(-142.8%) | -$120.20 K(-46.8%) | $817.00 K(+15.8%) |
| Sep 2007 | - | -$225.80 K(+30.7%) | $705.40 K(-81.9%) |
| Jun 2007 | - | -$172.80 K(-112.9%) | $3.91 M(-2.2%) |
| Mar 2007 | - | $1.34 M(-676.3%) | $4.00 M(-309.3%) |
| Dec 2006 | -$1.91 M(+1366.6%) | -$231.80 K(-107.8%) | -$1.91 M(+9.5%) |
| Sep 2006 | - | $2.98 M(-3684.6%) | -$1.74 M(-63.6%) |
| Jun 2006 | - | -$83.00 K(-98.2%) | -$4.78 M(+1.8%) |
| Mar 2006 | - | -$4.57 M(+6866.3%) | -$4.70 M(+3506.2%) |
| Dec 2005 | -$130.20 K(-52.6%) | -$65.60 K(0.0%) | -$130.30 K(-36.8%) |
| Sep 2005 | - | -$65.60 K(-3081.8%) | -$206.30 K(-24.7%) |
| Jun 2005 | - | $2200.00(-269.2%) | -$273.80 K(-0.8%) |
| Mar 2005 | - | -$1300.00(-99.1%) | -$276.00 K(+0.5%) |
| Dec 2004 | -$274.70 K(<-9900.0%) | -$141.60 K(+6.4%) | -$274.70 K(+106.4%) |
| Sep 2004 | - | -$133.10 K(<-9900.0%) | -$133.10 K(<-9900.0%) |
| Jun 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2003 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2003 | - | $0.00(0.0%) | -$300.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | -$300.00(0.0%) |
| Dec 2002 | -$300.00(<-9900.0%) | $0.00(-100.0%) | -$300.00(0.0%) |
| Sep 2002 | - | -$300.00(<-9900.0%) | -$300.00(<-9900.0%) |
| Jun 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00 | $0.00 |
FAQ
- What is Alaunos Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual CFI year-on-year change?
- What is Alaunos Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly CFI year-on-year change?
- What is Alaunos Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM CFI year-on-year change?
What is Alaunos Therapeutics annual cash flow from investing activities?
The current annual CFI of TCRT is $1.35 M
What is the all time high annual CFI for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual cash flow from investing activities is $1.35 M
What is Alaunos Therapeutics annual CFI year-on-year change?
Over the past year, TCRT annual cash flow from investing activities has changed by +$1.54 M (+797.41%)
What is Alaunos Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TCRT is $0.00
What is the all time high quarterly CFI for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly cash flow from investing activities is $2.98 M
What is Alaunos Therapeutics quarterly CFI year-on-year change?
Over the past year, TCRT quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Alaunos Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TCRT is $1.50 M
What is the all time high TTM CFI for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM cash flow from investing activities is $4.00 M
What is Alaunos Therapeutics TTM CFI year-on-year change?
Over the past year, TCRT TTM cash flow from investing activities has changed by -$1000.00 (-0.07%)